Heather Maecker

7.9k citations

18 papers · 3.0k indexed · 2 hit papers · h-index 14

Impact in

Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses

Papers in ⓘ

Oncology 11
- Cancer Immunotherapy and Biomarkers 5
- Cancer-related Molecular Pathways 4
- CAR-T cell therapy research 3
Biological Psychiatry 1

Co-authors: Amato J. Giaccia (2 shared papers)Zhong Yun (1 shared paper)Randall S. Johnson (1 shared paper)Eugene Varfolomeev (3 shared papers)Dorothy French (2 shared papers)Jinfeng Liu (2 shared papers)Vishva M. Dixit (2 shared papers)Domagoj Vucic (2 shared papers)
Journals: Nature (2 papers)Cell (2 papers)Molecular Cancer Therapeutics (1 paper)Brain Research (1 paper)Immunity (1 paper)
Partner nations: United States France Australia

In The Last Decade

Heather Maecker

18 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade 2016 · 527 citations

Peers

Countries citing papers authored by Heather Maecker

Since Specialization

Citations

This map shows the geographic impact of Heather Maecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Maecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Maecker more than expected).

Fields of papers citing papers by Heather Maecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Maecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Maecker. The network helps show where Heather Maecker may publish in the future.

Co-authors

The 25 scholars most cited alongside Heather Maecker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Heather Maecker Line = papers co-authored together Heather Maecker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade Immunity ·Peter Ebert, Jeanne Cheung, Yagai Yang, Erin McNamara, Rebecca Hong, Марина Москаленко, Stephen E. Gould, Heather Maecker, Bryan Irving, Jeong Kim, Marcia Belvin, Ira Mellman Hit paper breakdown →	2016	527
2	Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival Nature ·Martin Schwickart, Xiaodong Huang, Jennie R. Lill, Jinfeng Liu, Ronald E. Ferrando, Dorothy French, Heather Maecker, Karen O’Rourke, Fernando Bazán, Jeffrey Eastham‐Anderson, Yue Peng, David Dornan, David C.S. Huang, Vishva M. Dixit Hit paper breakdown →	2009	510
3	Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer Nature ·Khaled Ali, Dalya R. Soond, Roberto Piñeiro, Thorsten Hagemann, Wayne Pearce, Ee Lyn Lim, Hicham Bouabe, Cheryl L. Scudamore, Timothy C. Hancox, Heather Maecker, Lori S. Friedman, Martin Turner, Klaus Okkenhaug, Bart Vanhaesebroeck	2014	397
4	Inhibition of PPARγ2 Gene Expression by the HIF-1-Regulated Gene DEC1/Stra13 Developmental Cell ·Zhong Yun, Heather Maecker, Randall S. Johnson, Amato J. Giaccia	2002	393
5	Molecular Determinants of Kinase Pathway Activation by Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand Journal of Biological Chemistry ·Eugene Varfolomeev, Heather Maecker, Darcie Sharp, David A. Lawrence, Mark Renz, Domagoj Vucic, Avi Ashkenazi	2005	221
6	USP1 Deubiquitinates ID Proteins to Preserve a Mesenchymal Stem Cell Program in Osteosarcoma Cell ·Samuel A. Williams, Heather Maecker, Dorothy French, Jinfeng Liu, Andrew Gregg, Leah B. Silverstein, Tim C. Cao, Richard A.D. Carano, Vishva M. Dixit	2011	211
7	TWEAK Attenuates the Transition from Innate to Adaptive Immunity Cell ·Heather Maecker, Eugene Varfolomeev, Frank Kischkel, David A. Lawrence, Heidi Leblanc, Wyne Lee, Stephen D. Hurst, Dimitry M. Danilenko, Jun Li, Ellen Filvaroff, Becky Yang, Dylan Daniel, Avi Ashkenazi	2005	202
8	Cellular Inhibitors of Apoptosis Are Global Regulators of NF-κB and MAPK Activation by Members of the TNF Family of Receptors Science Signaling ·Eugene Varfolomeev, Tatiana Goncharov, Heather Maecker, Kerry Zobel, László G. Kömüves, Kurt Deshayes, Domagoj Vucic	2012	161
9	The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo Molecular Cancer Therapeutics ·Jun Chen, Sha Jin, Vivek Abraham, Xiaoli Huang, Bernard A. Liu, Michael J. Mitten, Paul Nimmer, Xiaoyu Lin, Morey L. Smith, Yu Shen, Alexander R. Shoemaker, Stephen K. Tahir, Haichao Zhang, Scott Ackler, Saul H. Rosenberg, Heather Maecker, Deepak Sampath, Joel Johansson, Chris Tse, Steven W. Elmore	2011	119
10	Exploration of the antibody–drug conjugate clinical landscape mAbs ·Heather Maecker, Vidya S. Jonnalagadda, Sunil Bhakta, Vasu Jammalamadaka, Jagath R. Junutula	2023	80
11	p53 promotes selection for Fas-mediated apoptotic resistance. PubMed ·Heather Maecker, Constantinos Koumenis, Amato J. Giaccia	2000	53
12	Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure Brain Research ·Heather Maecker, Aparna R. Desai, Rajesh Dash, Jean Rivier, Wylie Vale, Robert M. Sapolsky	1997	52
13	Endocrine Modulators of Necrotic Neuron Death Brain Pathology ·Raphael J. Chan, Edward D. Huey, Heather Maecker, Karen M. Cortopassi, Sarah A. Howard, Asha Iyer, Laura J. Mclntosh, Olusola Ajilore, Sheila M. Brooke, Robert M. Sapolsky	1996	34
14	Perinatal cocaine exposure inhibits the development of the male SDN Developmental Brain Research ·Heather Maecker	1993	14
15	409 Optimizing the Therapeutic Potential of PD-L1 Blockade as a Single Agent and Through Combination Therapy European Journal of Cancer ·Bryan Irving, Heather Maecker, Yanmin Yang, Марина Москаленко, Jeanne Cheung, D. Chen	2012	2
16	Qualification of an intracellular cytokine staining (ICS) assay to evaluate mucin 1-specific T cell responses in ovarian cancer patients treated with CVAC immunotherapy Cytotherapy ·Sharron Gargosky, Sheena Gupta, Heather Maecker	2013	1
17	MAP kinase inhibitors stimulate T cell and anti-tumor activity in combination with blockade of the PD-L1/PD-1 interaction Journal for ImmunoTherapy of Cancer ·Bryan Irving, Jeanne Cheung, Yagai Yang, Marina Moskalenka, Marcin Kowanetz, Heather Maecker, Ira Mellman	2013	1
18	A Critical Role for PIM2 Kinase in Multiple Myeloma Through NF-κB Activation Blood ·Veerendra Munugalavadla, Leanne Berry, Jae H. Chang, Geoffrey Del Rosario, Jake Drummond, Changchun Du, Karen Fitzgerald, Lori S. Friedman, Stephen E. Gould, Heather Maecker, John G. Moffat, Dionysos Slaga, Xiaojing Xiaojing, Kristina West, Shang‐Fan Yu, Allen Ebens	2011	1

About Heather Maecker

Heather Maecker is a scholar working on Oncology, Biological Psychiatry, Immunology, Behavioral Neuroscience and Cancer Research, having authored 18 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer-related Molecular Pathways (4 papers), Cell death mechanisms and regulation (4 papers), CAR-T cell therapy research (3 papers), Immune Cell Function and Interaction (3 papers), NF-κB Signaling Pathways (3 papers), Melanoma and MAPK Pathways (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (852 citations), Cancer Research (587 citations), Molecular Biology (1.7k citations) and Genetics (213 citations). Heather Maecker has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Amato J. Giaccia, Zhong Yun, Randall S. Johnson, Eugene Varfolomeev, Dorothy French, Jinfeng Liu, Vishva M. Dixit, Domagoj Vucic, Avi Ashkenazi and David A. Lawrence. Their work appears in journals such as Nature, Cell, Molecular Cancer Therapeutics, Brain Research and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact